Published in Br J Ophthalmol on June 01, 2005
Perimysial fibroblasts of extraocular muscle, as unique as the muscle fibers. Invest Ophthalmol Vis Sci (2009) 0.92
Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease. J Biol Chem (2010) 0.91
Functional expression of the thyrotropin receptor in C cells: new insights into their involvement in the hypothalamic-pituitary-thyroid axis. J Anat (2009) 0.83
Selenium supplementation in thyroid associated ophthalmopathy: an update. Int J Ophthalmol (2014) 0.81
Thyroid-associated orbitopathy is linked to gastrointestinal autoimmunity. Clin Exp Immunol (2014) 0.79
Graves orbitopathy: a perspective. Nat Rev Endocrinol (2009) 0.77
Blocking type TSH receptor antibodies. Auto Immun Highlights (2012) 0.77
Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis). Trans Am Ophthalmol Soc (2010) 0.75
Ophthalmologic manifestations of celiac disease. Int J Ophthalmol (2016) 0.75
Expression of TSH-R in normal human extraocular muscles. Br J Ophthalmol (2006) 0.75
Extrathyroidal manifestations of Graves' disease: the thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissues. J Clin Endocrinol Metab (2001) 2.29
Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet (1993) 2.13
Classification of eye changes of Graves' disease. Thyroid (1992) 1.66
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) (2000) 1.61
Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab (1998) 1.59
Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab (1999) 1.59
Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol (1998) 1.38
The initial clinical characteristics of Graves' orbitopathy vary with age and sex. Arch Ophthalmol (1993) 1.38
Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest (2000) 1.31
Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf) (1993) 1.30
Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology (1984) 1.28
Ocular changes in Graves' disease. A long-term follow-up study. Q J Med (1960) 1.27
Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol Cell Physiol (2000) 1.27
Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metab (1979) 1.09
Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci (2000) 1.09
Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab (1997) 1.07
The thyrotropin receptor in thyroid eye disease. Thyroid (1998) 1.06
Development of an animal model of autoimmune thyroid eye disease. J Immunol (1999) 1.05
Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metab (1969) 1.00
Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab (1994) 0.99
Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol (1995) 0.98
Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy. Thyroid (1995) 0.91
Analysis of orbital T cells in thyroid-associated ophthalmopathy. Clin Exp Immunol (1998) 0.88
Graves' disease is a multi-system autoimmune disorder in which extra ocular muscle damage and connective tissue inflammation are variable features. Thyroid (2002) 0.84
Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem (2000) 2.70
Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. Am J Respir Cell Mol Biol (2001) 2.37
Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32
Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet (1998) 1.91
Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues. J Clin Endocrinol Metab (1994) 1.65
Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J (2002) 1.64
Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun (1989) 1.57
Evoked potentials investigation of visual dysfunction after methanol poisoning. Crit Care Med (1999) 1.55
Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. J Clin Endocrinol Metab (2000) 1.54
Identification of the thyroid Na+/I- cotransporter as a potential autoantigen in thyroid autoimmune disease. Eur J Endocrinol (1995) 1.40
Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol (1998) 1.38
[Unnecessary surgery in cases of fully accommodative esotropia]. J Fr Ophtalmol (1991) 1.38
Fitting the distributions of length of stay by parametric models. Med Care (1998) 1.36
The dramatic reality of biliary tract injury during laparoscopic cholecystectomy. An anonymous multicenter Belgian survey of 65 patients. Surg Endosc (1997) 1.35
Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab (2005) 1.33
Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol (2003) 1.33
Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest (2000) 1.31
A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor. J Biol Chem (2001) 1.29
Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) (2003) 1.27
Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. Biochem Biophys Res Commun (1990) 1.27
Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med (1998) 1.24
The thyrotropin receptor in thyroid diseases. N Engl J Med (1997) 1.24
Anion selectivity by the sodium iodide symporter. Endocrinology (2003) 1.16
Analysis of sequence and structure homologies between thyroglobulin and acetylcholinesterase: possible functional and clinical significance. Biochem Biophys Res Commun (1986) 1.16
Mapping thyroid peroxidase epitopes using recombinant protein fragments. Eur J Endocrinol (1995) 1.10
Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci (2000) 1.09
Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation (1997) 1.09
Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Thyroid (2001) 1.08
Current insights into the pathogenesis of Graves' orbitopathy. Horm Metab Res (2009) 1.08
New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Hum Reprod (2004) 1.08
Lymphatic malformations of the head and neck: a retrospective review and a support for staging. Head Neck (2001) 1.08
Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab (1997) 1.07
Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8. J Clin Endocrinol Metab (2001) 1.06
The thyrotropin receptor in thyroid eye disease. Thyroid (1998) 1.06
Thyroperoxidase, an auto-antigen with a mosaic structure made of nuclear and mitochondrial gene modules. EMBO J (1987) 1.05
Development of an animal model of autoimmune thyroid eye disease. J Immunol (1999) 1.05
Direct toxic effect of iodide in excess on iodine-deficient thyroid glands: epithelial necrosis and inflammation associated with lipofuscin accumulation. Exp Mol Pathol (1986) 1.04
Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) (1995) 1.02
Prevalence of thyroid cancer in Graves' disease: a retrospective study of a cohort of 103 patients treated surgically. Eur J Intern Med (2003) 1.02
Muscle autoantigens in thyroid associated ophthalmopathy: the limits of molecular genetics. J Endocrinol Invest (1993) 1.02
Dicopper(II) complexes of H-BPMP-type ligands: pH-induced changes of redox, spectroscopic ((19)F NMR studies of fluorinated complexes), structural properties, and catecholase activities. Inorg Chem (2002) 1.02
Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. J Clin Endocrinol Metab (1997) 1.01
Cloning and sequencing of a novel 64-kDa autoantigen recognized by patients with autoimmune thyroid disease. J Clin Endocrinol Metab (1991) 1.00
Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol (1997) 1.00
Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies. Diabetologia (2006) 0.99
Complete nucleotide sequence of the human thyroperoxidase-microsomal antigen cDNA. Nucleic Acids Res (1987) 0.98
A new bacterial dehydrogenase oxidizing the lignin model compound guaiacylglycerol beta-O-4-guaiacyl ether. Biochimie (1985) 0.98
Peroxiredoxin 5 expression in the human thyroid gland. Thyroid (2005) 0.97
Towards an antigenic map of human thyroglobulin: identification of ten epitope-bearing sequences within the primary structure of thyroglobulin. J Endocrinol (1989) 0.96
Regulation and tissue distribution of the human sodium iodide symporter gene. Clin Endocrinol (Oxf) (1998) 0.96
Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett (1997) 0.95
Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol (2002) 0.94
Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model. Endocrinology (1994) 0.94
Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism. Thyroid (2000) 0.93
Two different entities of spontaneous ovarian hyperstimulation in a woman with FSH receptor mutation. Reprod Biomed Online (2010) 0.93
The prevalence and progression of autoimmune thyroid disease in the elderly. Acta Endocrinol (Copenh) (1984) 0.93
Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol (1996) 0.93
Lung fibrosis induced by silica particles in NMRI mice is associated with an upregulation of the p40 subunit of interleukin-12 and Th-2 manifestations. Am J Respir Cell Mol Biol (1999) 0.92
The W546X mutation of the thyrotropin receptor gene: potential major contributor to thyroid dysfunction in a Caucasian population. J Clin Endocrinol Metab (2003) 0.92
Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin. J Endocrinol Invest (1993) 0.92
The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J Endocrinol (1998) 0.92
Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab (1997) 0.90
Variants of the BMP15 gene in a cohort of patients with premature ovarian failure. Hum Reprod (2010) 0.90
A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J Cell Biol (1998) 0.89
Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context. Endocrinology (2003) 0.89
Examination of non-genetic factors affecting the growth performance of djallonke sheep in soudanian zone at the Okpara breeding farm of Benin. Trop Anim Health Prod (2006) 0.89
Contributions of the video-assisted approach to thyroid and parathyroid surgery. Acta Chir Belg (2002) 0.89
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis. Acta Neurol Belg (2001) 0.88
Homology between thyroglobulin and acetylcholinesterase: an explanation for pathogenesis of Graves' ophthalmopathy? Lancet (1986) 0.88
Dehydroepiandrosterone (DHEA) treatment in vitro inhibits adipogenesis in human omental but not subcutaneous adipose tissue. Mol Cell Endocrinol (2010) 0.88
The specificity of binding of glycoprotein hormones to their receptors. Cell Mol Life Sci (2008) 0.88
A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. Eur J Endocrinol (2001) 0.87
Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. J Clin Endocrinol Metab (1993) 0.87
Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology (2001) 0.87
Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J Clin Endocrinol Metab (2003) 0.87
Thyroperoxidase, but not the thyrotropin receptor, contains sequential epitopes recognized by autoantibodies in recombinant peptides expressed in the pUEX vector. J Clin Endocrinol Metab (1991) 0.87
Identification of high molecular weight forms of inositol 1,4,5-trisphosphate 3-kinase in rat thymus and human lymphocytes. Cell Signal (1994) 0.86
Development of a luminescent bioassay for thyroid stimulating antibodies. J Clin Endocrinol Metab (1999) 0.86
Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R. Biochem Biophys Res Commun (1994) 0.86
A new bacterial alcohol dehydrogenase active on degraded lignin and several low molecular weight aromatic compounds. FEMS Microbiol Lett (1989) 0.86
Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor. Eur J Endocrinol (1996) 0.85
Purification and characterization of a soluble bioactive amino-terminal extracellular domain of the human thyrotropin receptor. Biochemistry (2001) 0.85
Biological activity of activating thyrotrophin receptor mutants: modulation by iodide. J Mol Endocrinol (2005) 0.85
Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery. Clin Nucl Med (2001) 0.84
Long term preservation of electronic health records. Recommendations in a large teaching hospital in Belgium. Stud Health Technol Inform (2000) 0.84
Activating mutations of TSH receptor. Ann Endocrinol (Paris) (2003) 0.84
A health economic model to assess the cost-effectiveness of PEG IFN alpha-2a and ribavirin in patients with mild chronic hepatitis C. J Viral Hepat (2007) 0.84
Assays for thyroid growth immunoglobulins and their clinical implications: methods, concepts, and misconceptions. Endocr Rev (1987) 0.84
Precocity of the endothelial proliferation during a course of rapid goitrogenesis. Acta Endocrinol (Copenh) (1984) 0.83
Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy. J Clin Endocrinol Metab (2014) 0.83
Complement component C9 in Graves' disease. Clin Endocrinol (Oxf) (1986) 0.83